Degradable stent system and preparation method thereof
The bending, flexibility and biocompatibility of existing stents in the blood vessels is solved by using scaffolding systems with degradable metal alloy support units and polymer ligation units within the blood vessels, combining biocoatings and fluorescent markers. The problem of insufficient achieves stable support and degradation in the blood vessels.
Patent Information
- Application Number
- CN202411171183.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-12-03
AI Technical Summary
Existing non-degradable stents may trigger inflammatory responses and restenosis during long-term intravascular indwelling, and their bending and flexibility are insufficient to suit the vascular areas that require movement and bending, and their biocompatibility leads to foreign body reactions. .
Using a scaffolding system consisting of a degradable metal alloy support unit and a polymer connection unit, and a biocoating and fluorescent marker are provided on the support unit. The bending and flexibility are improved through the series connection unit and the biocoating is passed through the biocoating. Improve biocompatibility.
The good bending and flexibility of the stent system in the blood vessel is achieved, reducing the risk of breakage and shedding, while improving biocompatibility and prolonging degradation time, and suitable for areas of blood vessels that require movement and bending.
Smart Images

Figure CN119055416A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of medical devices, and in particular relates to a degradable stent system and a preparation method thereof. Background Art
[0002] Severe vascular diseases, especially vascular occlusive diseases, will have a significant impact on the body and require surgery to open the blood vessels. The most common method is to use vascular intervention technology to deliver stents to the affected area of the blood vessel to open the blood vessel.
[0003] Currently, the stents widely used in clinical practice are all non-degradable stents, which are mostly made of stainless steel alloys. Although they have good mechanical properties, their long-term retention in the body may cause complications such as inflammatory reactions and endothelial hyperplasia, which can easily lead to restenosis of blood vessels. In addition, these permanent stents cannot naturally combine with biological tissues, which may cause foreign body reactions and patients need to take long-term medication.
[0004] In recent years, degradable stents have gradually become a research hotspot. Magnesium alloys have become ideal materials for degradable stents due to their good biocompatibility and appropriate degradation rate. However, existing magnesium alloy stents have poor bendability and flexibility and are not suitable for vascular areas such as the knee joint that often require movement and bending, and their compatibility with blood vessels still needs to be improved. Summary of the invention
[0005] The object of the present invention is to provide a degradable stent system with better bendability, flexibility and biocompatibility and a preparation method thereof.
[0006] In order to achieve the above object, the technical solution adopted by the present invention is:
[0007] A degradable stent system, comprising:
[0008] A support unit, the support unit having a plurality of support units arranged along the axial direction thereof and being made of a degradable metal alloy;
[0009] A connecting unit, wherein the connecting unit is disposed between two adjacent supporting units, and both ends of the connecting unit are respectively connected to the two adjacent supporting units, and the connecting unit is made of a degradable high molecular polymer;
[0010] A degradable biological coating, the biological coating comprising an outer coating disposed on the outside of the support unit and an inner coating disposed on the inside of the support unit;
[0011] A fluorescent marker is coated on the outside of the outer coating layer.
[0012] The present invention connects a plurality of support units in series by using a connecting unit. The connecting unit is made of a degradable high molecular polymer, which has better bendability and flexibility. The stent system is used in vascular areas such as the knee joint that often need to move and bend. The connecting unit can be deformed and bent with the bending of the blood vessel without causing breakage or falling off. At the same time, the support units are relatively independent of each other and do not affect the support effect of the stent system. Further, by setting a biological coating, on the one hand, the biocompatibility of the stent system can be improved and the degradation time can be extended; on the other hand, it can further improve the flexibility and bendability of the support unit. The design of the fluorescent marker facilitates non-invasive observation of the position and degradation process of the stent.
[0013] Preferably, the metal alloy is a Mg-Ca series magnesium alloy.
[0014] In some embodiments, based on the total mass of the Mg-Ca series magnesium alloy being 100%, the Mg-Ca series magnesium alloy comprises the following components:
[0015] Magnesium 97.3-98.8%;
[0016] Calcium 0.5-0.7%;
[0017] Zinc 0.5-1%;
[0018] Manganese 0.1-0.5%;
[0019] Zirconium 0.1~0.5%.
[0020] By adding zinc, the strength and hardness of the alloy can be increased; by adding manganese, the corrosion resistance of the alloy can be improved; by adding zirconium, the grains can be refined and the mechanical properties of the alloy can be improved.
[0021] Preferably, the high molecular polymer is formed by cross-linking polydioxanone.
[0022] Preferably, the biological coating is formed by cross-linking collagen.
[0023] Preferably, the fluorescent marker is a fluorescent protein.
[0024] Preferably, the support unit has a hollow cylindrical structure, which includes a plurality of hollow groups arranged axially thereof, the hollow group includes a ring body and a support bar, the ring body is spindle-shaped; the support bar has two strips staggered in the ring body, which divide the hollow group into four hollow parts, and two adjacent hollow groups share one hollow part.
[0025] Further preferably, a limiting groove is provided on the outer end portion of the hollow portion located on the outer side, and the connecting unit is rotatably connected to the limiting groove.
[0026] In some embodiments, the support unit is formed by laser cutting from a hollow cylinder.
[0027] Preferably, the connection unit has a plurality of connection members arranged around the axis of the support unit, and the connection members are formed by connecting strip-shaped membranes end to end.
[0028] Preferably, the stent system further comprises an intermediate coating layer provided between the support unit and the inner coating layer and / or the outer coating layer, and the intermediate coating layer is made of a degradable high molecular polymer.
[0029] In some embodiments, the degradable high molecular polymer is polydioxanone.
[0030] The present invention also provides a method for preparing the above-mentioned degradable stent system, comprising the following steps:
[0031] (1) Cutting a biodegradable metal alloy hollow cylinder into a target shape to form a support unit;
[0032] (2) Pass one end of the strip membrane through two adjacent support units in sequence and connect it to the other end, repeat this step to connect multiple units in series;
[0033] (3) soaking the plurality of support units connected in series in step (2) in a solution containing a degradable biological raw material to form a biofilm, then soaking them in a cross-linking solution containing a cross-linking agent, and finally washing and drying them to form a bio-coating;
[0034] (4) Immersing the stent of step (3) in a solution containing a fluorescent marker, and attaching the fluorescent marker to the biological coating.
[0035] Preferably, in step (2), the thickness of the strip-shaped membrane is not greater than the thickness of the supporting unit.
[0036] Preferably, the strip-shaped membrane is prepared by cutting a polydioxanone film into strips and then immersing the strips in a solution containing a cross-linking agent, wherein the cross-linking agent includes glutaraldehyde and / or 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
[0037] Preferably, in step (3), the cross-linking agent is selected from one or more of glutaraldehyde, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, and N-hydroxysuccinimide.
[0038] Due to the application of the above technical solution, the present invention has the following advantages compared with the prior art:
[0039] The stent system of the present invention has a plurality of mutually independent support units, which are connected in series via a connecting unit. The connecting unit is made of a degradable high molecular polymer, has better bendability and flexibility, can deform and bend under stress, and will not break or fall off; a biological coating is also provided on both the inner and outer sides of the support unit, which improves the biocompatibility of the stent system while further improving the flexibility and bendability of the support unit. Therefore, the stent system is particularly suitable for vascular areas such as the knee joint that often require movement and bending. BRIEF DESCRIPTION OF THE DRAWINGS
[0040] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.
[0041] Figure 1 is a schematic structural diagram of the support system of Example 1;
[0042] Figure 2 This is a structural exploded view of the support system of Example 1;
[0043] Figure 3 This is a schematic diagram of the structure of the stent system of Example 1 without showing the biological coating;
[0044] Figure 4 This is a structural exploded view of the support unit and the biological coating of Example 1;
[0045] Figure 5 This is a schematic structural diagram of the support unit of Example 1;
[0046] Figure 6 is a side view of the support unit of Example 1;
[0047] Figure 7 This is a connection diagram of the connecting piece of Example 1;
[0048] Wherein: 1. support unit; 11. first hollow portion; 12. second hollow portion; 13. third hollow portion; 14. fourth hollow portion; 15. limit groove;
[0049] 2. Connecting unit; 21. Connecting piece;
[0050] 3. Biological coating; 31. Outer coating; 32. Inner coating. DETAILED DESCRIPTION
[0051] In the following, only some exemplary embodiments are briefly described. As those skilled in the art will appreciate, the described embodiments may be modified in various ways without departing from the spirit or scope of the embodiments of the present invention. Therefore, the drawings and descriptions are considered to be exemplary and non-restrictive in nature.
[0052] In the description of the embodiments of the present invention, it should be understood that the terms "far" and "near" and the like indicate positions or positional relationships defined by the position of the support system when in use, wherein the side close to the operator is the proximal end, and the side away from the operator is the distal end. This is only for the convenience of describing the embodiments of the present invention and simplifying the description, and does not indicate or imply that the device or element referred to must have a specific position, be constructed and operate in a specific position, and therefore cannot be understood as limiting the embodiments of the present invention.
[0053] In addition, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of the features. In the description of the embodiments of the present invention, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined.
[0054] In the embodiments of the present invention, unless otherwise clearly specified and limited, a first feature being "above" or "below" a second feature may include the first and second features being in direct contact, or may include the first and second features being in contact not directly but through another feature between them. Moreover, a first feature being "above", "above" and "above" a second feature includes the first feature being directly above and obliquely above the second feature, or simply indicates that the first feature is higher in level than the second feature. A first feature being "below", "below" and "below" a second feature includes the first feature being directly below and obliquely below the second feature, or simply indicates that the first feature is lower in level than the second feature.
[0055] The disclosure below provides many different embodiments or examples to implement different structures of the embodiments of the present invention. In order to simplify the disclosure of the embodiments of the present invention, the parts and settings of specific examples are described below. Of course, they are only examples, and the purpose is not to limit the embodiments of the present invention. In addition, the embodiments of the present invention can repeat reference numbers and / or reference letters in different examples, and this repetition is for the purpose of simplification and clarity, which itself does not indicate the relationship between the various embodiments and / or settings discussed.
[0056] The embodiments of the present invention are described in detail below with reference to the accompanying drawings.
[0057] Example 1
[0058] A degradable stent system, such as Figures 1 to 7 As shown, it includes a support unit 1, a connection unit 2, a degradable biological coating 3 and a fluorescent marker (not shown in the figure).
[0059] The support unit 1 has a plurality of support units 1 arranged along its axial direction. The number of support units 1 is not limited and can be designed according to actual needs. The shape and size of each support unit 1 can be the same or different, and can be specifically designed according to the actual blood vessel conditions. In this embodiment, each support unit 1 has the same shape and size. The following is a detailed description of the hollowing of one of the support units 1 as an example.
[0060] See also Figure 5 and Figure 6 , the support unit 1 has a hollow cylindrical structure, which includes a plurality of hollow groups arranged around its axial direction. Preferably, there are 2 to 6 hollow groups, more preferably 4 to 6, and in this embodiment, there are 5 hollow groups. The hollow group consists of a ring body and a support bar, wherein the ring body is spindle-shaped with a large middle and small ends, and the middle part of the ring body is bent outward in an arc shape; the support bar has two strips staggered in the ring body, which divide the hollow group into four hollow parts, namely, the first hollow part 11 and the second hollow part 12 arranged on the upper and lower sides, and the third hollow part 13 and the fourth hollow part 14 arranged on the far and near sides. Two adjacent hollow groups share a hollow part, specifically, the third hollow part 13 and the fourth hollow part 14 are shared, and the third hollow part 13 of one hollow group is the fourth hollow part 14 of another hollow group adjacent to it. The ring body of the spindle-shaped structure has good supporting performance, and the staggered support bars further enhance the supporting effect. Furthermore, a limiting groove 15 is provided on the outer end of the hollow portion located on the outer side, that is, a limiting groove 15 is provided on the outer side of the third hollow portion 13 and the fourth hollow portion 14 .
[0061] The support unit 1 is made of a degradable metal alloy, including but not limited to Mg-Ca magnesium alloy, such as Mg-0.6%Ca magnesium alloy. In this embodiment, the components of the Mg-Ca magnesium alloy include 97.3-98.8% magnesium, 0.5-0.7% calcium, 0.5-1% zinc, 0.1-0.5% manganese, and 0.1-0.5% zirconium. The addition of zinc, manganese, and zirconium is beneficial to improving the mechanical properties and corrosion resistance of the alloy.
[0062] Two adjacent support units 1 are connected by a connection unit 2, and the connection unit 2 includes a plurality of connection members 21 distributed axially around the support unit 1. Preferably, the connection members 21 are arranged one by one in correspondence with the hollowing groups. The two ends of the connection member 21 are respectively connected to the two adjacent support units 1. Specifically, the connection member 21 is formed by connecting a strip-shaped membrane end to end, and the two ends are respectively rotatably connected to the limit groove 15 of the support unit 1.
[0063] Furthermore, the strip-shaped membrane is made of a degradable high molecular polymer, specifically polydioxanone formed by cross-linking. The connector 21 made of high molecular polymer has better flexibility and bendability, and can be deformed and bent under stress without breaking or falling off.
[0064] The degradable biological coating 3 includes an outer coating 31 disposed on the outer side of the support unit 1 and an inner coating 32 disposed on the inner side of the support unit 1. Optionally, the biological coating 3 may also be disposed on both the inner and outer sides of the connecting unit 2. The biological coating 3 is preferably made of collagen that has been cross-linked. Collagen has good biocompatibility and can also promote the rapid growth of vascular endothelial cells, which can effectively avoid complications after the stent system is implanted.
[0065] The fluorescent marker is coated on the outside of the outer coating 31, which can realize in vivo detection, thereby facilitating the observation of the location and degradation process of the stent system. The fluorescent marker is preferably sfGFP fluorescent protein.
[0066] The preparation method of the above-mentioned stent system comprises the following steps:
[0067] S1. Prepare support unit 1:
[0068] S1.1. Prepare a metal alloy material according to the following formula. Taking the total mass of the metal alloy as 100%, the metal alloy includes 97.3-98.8% magnesium, 0.5-0.7% calcium, 0.5-1% zinc, 0.1-0.5% manganese, and 0.1-0.5% zirconium;
[0069] S1.2, placing each metal into a melting furnace, heating until completely melted, and then cooling and casting into a hollow cylindrical structure;
[0070] S1.3, homogenizing annealing the metal alloy with a hollow cylindrical structure to eliminate component segregation and internal stress generated during the casting process, specifically including: annealing in a vacuum or inert gas environment at 300°C to 350°C for 2 to 4 hours, and slowly cooling to room temperature;
[0071] S1.4, laser cutting the annealed metal alloy to form a support unit 1;
[0072] S1.5, performing surface passivation treatment on the support unit 1 to remove oxides and impurities generated during the cutting process, forming a protective film, and improving corrosion resistance, specifically comprising: soaking the support unit 1 in S1.4 in a dilute acid (such as a 1% to 3% nitric acid solution) for 5 to 10 minutes, and then rinsing with pure water;
[0073] S1.6, selectively coating the surface of the support unit 1 with an intermediate coating, specifically comprising: immersing the support unit 1 in S1.5 in a solution containing a degradable polymer with a concentration of 5% (w / v) (the solute is polydioxanone, and the solvent is dichloromethane or ethyl acetate), adjusting the immersion time according to the required thickness, taking it out and waiting for the solvent to evaporate, and placing it in an inert gas until solidified;
[0074] S2. Preparation of connection unit 2:
[0075] S2.1, select a polydioxanone (PDS) film with a thickness not greater than that of the stent ring, cut it into strips, and then immerse it in a solution containing a cross-linking agent (glutaraldehyde and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide) for cross-linking to make a connector 21;
[0076] S2.2, pass one end of the connecting piece 21 through the limiting grooves 15 of two adjacent supporting units 1 in sequence and weld it to the other end, and repeat this step until multiple supporting units 1 are connected in series;
[0077] S3. Preparation of biological coating 3:
[0078] S3.1. Prepare collagen solution: weigh collagen powder (high-purity type I collagen, commercially available) and add it to deionized water or PBS buffer to prepare a collagen solution with a concentration of 0.5-1% (w / v);
[0079] S3.2, soaking the scaffold prepared in S2.2 in a collagen solution, so that the collagen is evenly attached to the inner and outer surfaces of the support unit 1, and then taking it out and drying it at room temperature;
[0080] S3.3, soaking the scaffold of S3.2 in a 0.1-1% glutaraldehyde solution for cross-linking, then rinsing with a large amount of deionized water or PBS buffer, and then placing in a vacuum oven or a clean environment, drying at 40-50°C for 24 hours to ensure that the collagen film is completely cured to form a bio-coating 3;
[0081] S4. Coating of fluorescent markers:
[0082] High-purity sfGFP fluorescent protein is dissolved in PBS buffer or deionized water, and then the S3.3 scaffold is immersed therein to ensure that the sfGFP protein is fully attached to the surface of the biological coating 3, and finally dried, cleaned and dried and fixed.
[0083] The above embodiments are only for illustrating the technical concept and features of the present invention, and their purpose is to enable people familiar with the technology to understand the content of the present invention and implement it accordingly, and they cannot be used to limit the protection scope of the present invention. Any equivalent changes or modifications made according to the spirit of the present invention should be included in the protection scope of the present invention.
Claims
1. A degradable stent system, characterized in that: The support system comprises: A support unit (1), the support unit (1) having a plurality of support units arranged along its axial direction and made of a degradable metal alloy; A connecting unit (2), the connecting unit (2) being arranged between two adjacent supporting units (1), with two ends thereof being respectively connected to the two adjacent supporting units (1), and the connecting unit (2) being made of a degradable high molecular polymer; A degradable biological coating (3), the biological coating (3) comprising an outer coating (31) arranged on the outside of the support unit (1) and an inner coating (32) arranged on the inside of the support unit (1); A fluorescent marker is coated on the outside of the outer coating layer (31).
2. The degradable stent system according to claim 1, characterized in that: The metal alloy is a Mg-Ca series magnesium alloy; and / or, The high molecular polymer is formed by cross-linking polydioxanone; and / or, The biological coating (3) is formed by cross-linking collagen; and / or, The fluorescent marker is fluorescent protein.
3. The degradable stent system according to claim 1, characterized in that: The support unit (1) has a hollow cylindrical structure, which includes a plurality of hollow groups arranged around its axial direction, the hollow group includes a ring body and a support bar, the ring body is spindle-shaped; the support bar has two strips staggered in the ring body, which divide the hollow group into four hollow parts, and two adjacent hollow groups share one hollow part.
4. The degradable stent system according to claim 3, characterized in that: A limiting groove (15) is provided on the outer end of the hollow portion located on the outside, and the end of the connecting unit (2) is rotatably connected to the limiting groove (15).
5. The degradable stent system according to claim 3 or 4, characterized in that: The support unit (1) is formed by laser cutting from a hollow ring.
6. The degradable stent system according to claim 1, characterized in that: The connection unit (2) comprises a plurality of connection members (21) arranged around the axis of the support unit (1), and the connection members (21) are formed by connecting strip-shaped membranes end to end.
7. The degradable stent system according to claim 1, characterized in that: The stent system further comprises an intermediate coating layer provided between the support unit (1) and the inner coating layer (32) and / or the outer coating layer (31), wherein the intermediate coating layer is made of a degradable high molecular polymer.
8. The method for preparing a degradable stent system according to any one of claims 1 to 7, characterized in that: The preparation method comprises the following steps: (1) cutting a biodegradable metal alloy hollow cylinder into a target shape to form a support unit (1); (2) passing one end of the strip-shaped membrane through two adjacent support units (1) in sequence and connecting it to the other end, and repeating this step to connect multiple support units (1) in series; (3) soaking the plurality of support units (1) connected in series in step (2) in a solution containing a degradable biological raw material to form a biofilm, then soaking them in a cross-linking solution containing a cross-linking agent, and finally washing and drying them to form a bio-coating (3); (4) Immersing the stent prepared in step (3) in a solution containing a fluorescent marker, and attaching the fluorescent marker to the biological coating (3).
9. The method for preparing a degradable stent system according to claim 1, characterized in that: In the step (2), the thickness of the strip-shaped membrane is not greater than the thickness of the support unit (1), and the strip-shaped membrane is made by cutting a polydioxanone film into strips and then immersing the strips in a solution containing a cross-linking agent, wherein the cross-linking agent includes glutaraldehyde and / or 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
10. The method for preparing a degradable stent system according to claim 1, characterized in that: In the step (3), the cross-linking agent is selected from one or more of glutaraldehyde, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, and N-hydroxysuccinimide.
